Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2007-06-13Clinical Trial Update: Comprehensive Management of Diabetic Patients With Renal Impairment : Impact on Blood Pressure and Glycemic Control [NA]
An update on a study evaluating comprehensive management of diabetic patients with renal impairment, focusing on effects on blood pressure a…
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Chicken-Diet vs. Enalapril to Reduce Albuminuria [NA]
A completed clinical trial comparing a chicken-based diet to enalapril for reducing albuminuria in people with microalbuminuria and diabetic…
-
CLINICAL_TRIALS trial_result · 2007-05-10Clinical Trial Update: Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy [Phase 4]
Phase 4 clinical trial update on doxazosin effects on ambulatory blood pressure monitoring in hypertensive patients with diabetic nephropath…
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy [NA]
The clinical trial evaluating a low-protein diet to prevent the progression of diabetic nephropathy has been terminated.
-
CLINICAL_TRIALS other · 2007-01-29Clinical Trial Update: Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients [Phase 4]
Clinical trial update on aspirin and enalapril in patients with type 2 diabetes and microalbuminuria (Phase 4); current status and results a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-01-08Clinical Trial Update: Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
This clinical trial update notes that the Higashi-Saitama trial evaluating pioglitazone for cardiovascular outcomes in patients with type 2 …
-
CLINICAL_TRIALS trial_result · 2006-11-23Clinical Trial Update: Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease [NA]
This clinical trial update discusses the maximal dose of an ACE inhibitor being studied for treating diabetic kidney disease, with the trial…
-
CLINICAL_TRIALS trial_result · 2006-10-17Clinical Trial Update: Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. [NA]
A completed clinical trial update evaluating how renin-angiotensin blocking drugs may maximize benefits in diabetic nephropathy.
-
CLINICAL_TRIALS trial_result · 2006-10-09Clinical Trial Update: Olmesartan Medoxomil and Diabetic Nephropathy [Phase 3]
A Phase 3 trial evaluating Olmesartan Medoxomil for diabetic nephropathy in type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Soy Protein in Early Diabetic Nephropathy [Phase 1, Phase 2]
This document reports a completed Phase 1/Phase 2 clinical trial evaluating soy protein in patients with early diabetic nephropathy. The stu…
-
CLINICAL_TRIALS trial_result · 2006-08-07Clinical Trial Update: Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy [NA]
A completed clinical trial evaluated how losartan affects insulin sensitivity and secretion in individuals with type 2 diabetes and diabetic…
-
FDA approval · 2006-07-03FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for lisinopril, authorizing the continued marketing of its lisinopril gene…
-
FDA approval · 2006-06-08FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
The FDA issued approval for a supplemental application for lisinopril from Heritage Pharmaceuticals (Avet), authorizing marketing of a gener…
-
CLINICAL_TRIALS trial_result · 2006-05-18Clinical Trial Update: Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria [Phase 4]
A Phase 4 trial completed evaluating the optimal dose of irbesartan for renoprotection in adults with type 2 diabetes mellitus and persisten…